Below you can find an overview of old and recent Wemos publications. For an overview of more recent publications on human resources for health, finance for health and medicines, please visit our knowledge platform Wemosresources.org.
Strategy 2019-2023, annual report & year overview 2019
Strategy 2019-2023 (extended version)
Previous annual reports
Wemos in 2017: an overview of our activities
For more previous annual reports and strategy documents, please visit this page
Infographics
2019 The System of Medicine Development (and what the EU and the Netherlands can do about it)
2019 Theory of Change
2019 Health systems: what are they? What is a good health system?
2018 Financing for Health (SDG3): Shared global responsibility – an analysis of five African countries
2018 Universal Health Coverage: a pool for a plan for UHC
Human resources for health
2020 Remco van de Pas and Corinne Hinlopen: Policy brief ‘Global Skills Partnerships on Migration’
2019 Uganda’s human resources for health: paradoxes and dilemmas (advocacy brief)
2018 Country report Malawi – Mind the funding gap: who is paying the health workers?
2018 Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich: Framing the Health Workforce Agenda Beyond Economic Growth
2018 Factsheet ‘Introduction to Health Labour Market Analysis’
2018 Factsheet ‘Human Resources for Health: Global Agreements’
2018 World Health Organization: current issues and advocacy opportunities for civil society organizations
2017 Linda Mans, Remco van de Pas, Sascha Marschang: Civil society contributions to a sustainable health workforce in the European Union (in: Public Health Panorama 2017; 3(3):357-536)
2016 Remco van de Pas, Linda Mans, e.a.: The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa
2015 HealthWorkers4All project: Collection of case studies
2015 Amy Davies and Linda Mans: Thuisbezorgd – inwonende buitenlandse zorgverleners als oplossing? (Dutch)
2014 HealthWorkers4All project: A health worker for everyone, everywhere! – EU booklet
2014 HealthWorkers4All project: Health workforce shortages and international mobility in the EU
2013 HealthWorkers4All project: An overview of code implementation in EU countries
2013 HealthWorkers4All project: Caring for carers – a relevant concern?
2013 HealthWorkers4All project: Zorgen voor zorgende handen – ver van ons bed? (Dutch)
Good governance & Finance for health
2020 Discussion paper (Aid & Trade): ‘In the interest of health for all? The Dutch ‘Aid & Trade’ agenda as pursued in the African healthcare context’ – Summary brief of this and our other Aid & Trade discussion paper in English and in Dutch
2020 Factsheet ‘The Global Financing Facility in Uganda: 2020 update’
2020 Factsheet: World Bank Trust Funds and the case of the Global Financing Facility: time for a refresh?
2020 Factsheet ‘The Global Financing Facility’
2020 Position paper: COVID-19, SSR&D e sistemas de saúde (Português)
2020 Position paper: COVID-19, SRHR and health systems
2020 A strong health system is a prerequisite for sexual and reproductive health and rights
2019 How healthy is a ‘healthy’ economy? Incompatibility between current pathways towards SDG3 and SDG8
2019 Discussion paper (Aid & Trade): ‘Best public value for public money? The case of match-funded multi-hospital infrastructure development in Tanzania’ – Summary brief of this and our other Aid & Trade discussion paper in English and in Dutch
2019 The Global Financing Facility in Tanzania
2019 The Global Financing Facility in Malawi
2019 The Global Financing Facility in Uganda
2019 The Global Financing Facility in Kenya
2019 Factsheet ‘Fiscal space for health and four ways to increase it’
2018 Factsheet ‘Public Finance Targets For Universal Health Coverage (UHC)’
Medicines
2020 Accountability at the EMA and risk of bias in pre-submission activities at the EMA (4-pager/summary) – Full report ‘Accountability of the EMA in marketing authorisation of new medicines’
2019 SOMO & Wemos: ‘Overpriced – Drugs developed with Dutch public funding’
2017 Ella Weggen and Corinne Hinlopen: ‘Independent clinical research: a road towards affordable & valuable medicines’
2017 Clinical trials in Africa: the cases of Egypt, Kenya, Zimbabwe and South Africa
2017 Pearl Heinemans, Irene Schipper, Patrick Durisch: ‘Transnational pharmaceutical companies’ clinical drug trials in Egypt: ethical questions in a challenging context’ in: Dirty Profits 5.
2016 ‘Industry-sponsored clinical drug trials: ethical questions in a challenging context’
2016 Annelies den Boer and Amy Davies: ‘Clinical trials in Africa: an exploitative relationship’ in: Dirty Profits 4.
2015 Clinical Trials Realities in Zimbabwe: Dealing with Possible Unethical Research
2015 Joint briefing paper: ”Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access’
2014 Position paper: ‘Added Therapeutic Value: European citizens should get their money’s worth’
2014 The Clinical Trials Industry in Kenya: Realities, Risks and Challenges
2013 The Clinical Trials Industry in South Africa: Ethics, Rules and Realities
2008 A Bitter Pill: The risks of carrying out clinical drug trials in developing countries
Harmful substances
2016 Wemos and WECF: ‘Measures against endocrine disrupting chemicals: the example of Denmark, Sweden and France’
Wemos
Ellermanstraat 15-O
1114 AK Amsterdam-Duivendrecht
T +31 020 435 20 50
E info@wemos.nl
Ellermanstraat 15-O
1114 AK Amsterdam-Duivendrecht
T +31 020 435 20 50
E info@wemos.nl
